Statistics
Publications
7
Citations
221
H-Index
7
Active since
2011
Venita Gresham Watson is an author at Constellation Pharmaceuticals (United States) specializing in medicine, cell biology, and immunology.
Publications per year
2011–2020
7
7
Pharmacogenomic Characterization of US FDA-approved Cytotoxic Drugs
Eric Peters, Alison A. Motsinger‐Reif, Tammy M. Havener et al. · Pharmacogenomics · 2011 · 46 citations · Full text
A Sensitive Luminescent Assay for the Histone Methyltransferase NSD1 and Other SAM-Dependent Enzymes
Katherine M. Drake, Venita Gresham Watson, Anne Kisielewski et al. · Assay and Drug Development Technologies · 2014 · 35 citations · Full text
Histone Modifications, Epigenetic Change, Histone Methyltransferase Nsd1 +19
Targeted Drug Discovery for Pediatric Leukemia
Andrew D. Napper, Venita Gresham Watson · Frontiers in Oncology · 2013 · 19 citations · Full text
Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors
Victor Gehling, John P. McGrath, Martin Duplessis et al. · ACS Medicinal Chemistry Letters · 2020 · 19 citations · Full text
1–5 of 7